TrialInternational journal of impotence research2021

Low intensity shockwave therapy in combination with phosphodiesterase-5 inhibitors is an effective and safe treatment option in patients with vasculogenic ED who are PDE5i non-responders: a multicenter single-arm clinical trial.

Alessandro Palmieri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.